This week the Senate Health, Education, Labor and Pensions Committee is scheduled to consider the Medication Affordability and Patent Integrity Act. Despite its name, the act would do nothing to actually lower prescription drug prices or improve drug patents.
The Wrong Prescription for Drug Affordability
Comment
Show comments
Hide Comments
